OraSure Technologies, Inc. (NASDAQ:OSUR)
CAPS Rating:
The Company develops, manufactures and markets oral specimen collection devices using its proprietary oral fluid technologies, diagnostic products including in vitro diagnostic tests, and other medical devices.
RSS Headlines
Fool UK
Recs
Beaten down recently on concerns over its HIV test and legal issues, but still has excellent prospects for its over-the-counter oral fluid HIV test and its hepatitis C test for healthcare professionals.